Loading...

Harrow Health, Inc. 11.875% Senior Notes due 2027

HROWMNASDAQ
HealthcareMedical - Pharmaceuticals
$25.98
$-0.06(-0.21%)

Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) AI-Powered Stock Analysis

See how Harrow Health, Inc. 11.875% Senior Notes due 2027 scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) Stock Overall Grade

Harrow Health, Inc. 11.875% Senior Notes due 2027’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Harrow Health, Inc. 11.875% Senior Notes due 2027's overall stock rating.

Forecast

A

Score

80/100

Financial Growth

C

Score

40/100

Fundamental Growth

C+

Score

51/100

Key Ratios

C

Score

44/100

Sector Comparison

B+

Score

75/100

Industry Comparison

B+

Score

70/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

C+

Score

50/100

Component Analysis Explained

Understand the key factors behind each Harrow Health, Inc. 11.875% Senior Notes due 2027 stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions